• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工智能计算的肝肾功能指数在诊断非酒精性脂肪性肝病患者轻度和中度肝脂肪变性中的评价。

Evaluation of Artificial Intelligence-Calculated Hepatorenal Index for Diagnosing Mild and Moderate Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease.

机构信息

Medical Imaging Center, Department of Radiology, Faculty of Medicine, Semmelweis University, Korányi S. u. 2/A., 1083 Budapest, Hungary.

Department of Internal Medicine and Oncology, Faculty of Medicine, Semmelweis University, Korányi S. u. 2/A., 1083 Budapest, Hungary.

出版信息

Medicina (Kaunas). 2023 Feb 27;59(3):469. doi: 10.3390/medicina59030469.

DOI:10.3390/medicina59030469
PMID:36984470
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10058464/
Abstract

: This study aims to evaluate artificial intelligence-calculated hepatorenal index (AI-HRI) as a diagnostic method for hepatic steatosis. : We prospectively enrolled 102 patients with clinically suspected non-alcoholic fatty liver disease (NAFLD). All patients had a quantitative ultrasound (QUS), including AI-HRI, ultrasound attenuation coefficient (AC,) and ultrasound backscatter-distribution coefficient (SC) measurements. The ultrasonographic fatty liver indicator (US-FLI) score was also calculated. The magnetic resonance imaging fat fraction (MRI-PDFF) was the reference to classify patients into four grades of steatosis: none < 5%, mild 5-10%, moderate 10-20%, and severe ≥ 20%. We compared AI-HRI between steatosis grades and calculated Spearman's correlation (r) between the methods. We determined the agreement between AI-HRI by two examiners using the intraclass correlation coefficient (ICC) of 68 cases. We performed a receiver operating characteristics (ROC) analysis to estimate the area under the curve (AUC) for AI-HRI. : The mean AI-HRI was 2.27 (standard deviation, ±0.96) in the patient cohort. The AI-HRI was significantly different between groups without (1.480 ± 0.607, < 0.003) and with mild steatosis (2.155 ± 0.776), as well as between mild and moderate steatosis (2.777 ± 0.923, < 0.018). AI-HRI showed moderate correlation with AC (r = 0.597), SC (r = 0.473), US-FLI (r = 0.5), and MRI-PDFF (r = 0.528). The agreement in AI-HRI was good between the two examiners (ICC = 0.635, 95% confidence interval (CI) = 0.411-0.774, < 0.001). The AI-HRI could detect mild steatosis (AUC = 0.758, 95% CI = 0.621-0.894) with fair and moderate/severe steatosis (AUC = 0.803, 95% CI = 0.721-0.885) with good accuracy. However, the performance of AI-HRI was not significantly different ( < 0.578) between the two diagnostic tasks. : AI-HRI is an easy-to-use, reproducible, and accurate QUS method for diagnosing mild and moderate hepatic steatosis.

摘要

这项研究旨在评估人工智能计算的肝肾功能指数(AI-HRI)作为诊断肝脂肪变性的一种方法。我们前瞻性纳入了 102 例临床疑似非酒精性脂肪性肝病(NAFLD)患者。所有患者均接受定量超声(QUS)检查,包括 AI-HRI、超声衰减系数(AC)和超声背向散射分布系数(SC)测量。还计算了超声脂肪肝指数(US-FLI)评分。磁共振成像脂肪分数(MRI-PDFF)为分类患者为四个脂肪变性等级的参考:无<5%、轻度 5-10%、中度 10-20%和重度≥20%。我们比较了 AI-HRI 在不同脂肪变性等级之间的差异,并计算了方法之间的 Spearman 相关系数(r)。我们使用 68 例患者的组内相关系数(ICC)来确定两名检查者之间 AI-HRI 的一致性。我们进行了受试者工作特征(ROC)分析,以估计 AI-HRI 的曲线下面积(AUC)。患者队列的平均 AI-HRI 为 2.27(标准差±0.96)。AI-HRI 在无(1.480±0.607,<0.003)和轻度脂肪变性组(2.155±0.776)之间以及轻度和中度脂肪变性组(2.777±0.923,<0.018)之间差异有统计学意义。AI-HRI 与 AC(r=0.597)、SC(r=0.473)、US-FLI(r=0.5)和 MRI-PDFF(r=0.528)均呈中度相关。两名检查者之间 AI-HRI 的一致性良好(ICC=0.635,95%置信区间[CI]:0.411-0.774,<0.001)。AI-HRI 可检测轻度脂肪变性(AUC=0.758,95%CI:0.621-0.894),中度/重度脂肪变性的准确性较高(AUC=0.803,95%CI:0.721-0.885)。然而,AI-HRI 在这两项诊断任务中的表现无显著差异(<0.578)。AI-HRI 是一种易于使用、可重复且准确的 QUS 方法,可用于诊断轻度和中度肝脂肪变性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac3/10058464/968aa3c2ad6a/medicina-59-00469-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac3/10058464/59d84d717176/medicina-59-00469-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac3/10058464/353a8d3d4aa1/medicina-59-00469-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac3/10058464/8913aafc60c3/medicina-59-00469-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac3/10058464/7090554f003d/medicina-59-00469-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac3/10058464/968aa3c2ad6a/medicina-59-00469-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac3/10058464/59d84d717176/medicina-59-00469-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac3/10058464/353a8d3d4aa1/medicina-59-00469-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac3/10058464/8913aafc60c3/medicina-59-00469-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac3/10058464/7090554f003d/medicina-59-00469-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ac3/10058464/968aa3c2ad6a/medicina-59-00469-g005.jpg

相似文献

1
Evaluation of Artificial Intelligence-Calculated Hepatorenal Index for Diagnosing Mild and Moderate Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease.人工智能计算的肝肾功能指数在诊断非酒精性脂肪性肝病患者轻度和中度肝脂肪变性中的评价。
Medicina (Kaunas). 2023 Feb 27;59(3):469. doi: 10.3390/medicina59030469.
2
Diagnostic performance of ultrasound hepatorenal index for the diagnosis of hepatic steatosis in children.超声肝肾指数诊断儿童肝脂肪变的效能。
Pediatr Radiol. 2022 Jun;52(7):1306-1313. doi: 10.1007/s00247-022-05313-x. Epub 2022 Mar 1.
3
Ultrasound-estimated hepatorenal index: diagnostic performance and interobserver agreement for pediatric liver fat quantification.超声估计的肝肾指数:用于儿童肝脏脂肪定量的诊断性能和观察者间一致性。
Pediatr Radiol. 2024 Sep;54(10):1653-1660. doi: 10.1007/s00247-024-06021-4. Epub 2024 Aug 13.
4
Liver Fat Quantification by Ultrasound in Children: A Prospective Study.超声在儿童肝脏脂肪定量中的应用:一项前瞻性研究。
AJR Am J Roentgenol. 2021 Oct;217(4):996-1006. doi: 10.2214/AJR.20.24874. Epub 2021 Jan 13.
5
Correlation and Performance of three Ultrasound Techniques to Stage Hepatic Steatosis in Nonalcoholic Fatty Liver Disease.三种超声技术对非酒精性脂肪性肝病肝脂肪变分期的相关性及效能比较。
Curr Med Imaging. 2024;20:1-12. doi: 10.2174/0115734056278434231213112035.
6
Diagnostic Performance of 9 Quantitative Ultrasound Parameters for Detection and Classification of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease.9 项定量超声参数在非酒精性脂肪性肝病患者肝脂肪变检测和分级中的诊断性能
Invest Radiol. 2022 Jan 1;57(1):23-32. doi: 10.1097/RLI.0000000000000797.
7
Liver Ultrasound Attenuation: An Ultrasound Attenuation Index for Liver Steatosis Assessment.肝脏超声衰减:一种用于评估肝脂肪变性的超声衰减指数。
Ultrasound Q. 2022 Jun 1;38(2):124-132. doi: 10.1097/RUQ.0000000000000605.
8
Early and accurate diagnosis of steatotic liver by artificial intelligence (AI)-supported ultrasonography.人工智能(AI)支持的超声检查对肝脂肪变性的早期准确诊断。
Eur J Intern Med. 2024 Jul;125:57-66. doi: 10.1016/j.ejim.2024.03.004. Epub 2024 Mar 14.
9
Reliability of ultrasound hepatorenal index and magnetic resonance imaging proton density fat fraction techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy as the reference standard.超声肝肾指数和磁共振成像质子密度脂肪分数技术在诊断肝脂肪变性中的可靠性,以磁共振波谱为参考标准。
PLoS One. 2021 Aug 12;16(8):e0255768. doi: 10.1371/journal.pone.0255768. eCollection 2021.
10
Two-dimensional Convolutional Neural Network Using Quantitative US for Noninvasive Assessment of Hepatic Steatosis in NAFLD.使用定量超声的二维卷积神经网络对非酒精性脂肪性肝病(NAFLD)患者肝脂肪变性进行无创评估
Radiology. 2023 Apr;307(1):e221510. doi: 10.1148/radiol.221510. Epub 2023 Jan 3.

引用本文的文献

1
Update of machine learning for ultrasound diagnosis of metabolic dysfunction-associated steatotic liver disease: a bright future for deep learning.用于代谢功能障碍相关脂肪性肝病超声诊断的机器学习进展:深度学习的光明未来。
PeerJ. 2025 Jun 30;13:e19645. doi: 10.7717/peerj.19645. eCollection 2025.
2
Artificial Intelligence in Liver Diseases: Recent Advances.人工智能在肝脏疾病中的应用:最新进展。
Adv Ther. 2024 Mar;41(3):967-990. doi: 10.1007/s12325-024-02781-5. Epub 2024 Jan 29.
3
Machine learning prediction of hepatic steatosis using body composition parameters: A UK Biobank Study.

本文引用的文献

1
Tissue attenuation imaging and tissue scatter imaging for quantitative ultrasound evaluation of hepatic steatosis.组织衰减成像和组织散射成像用于定量超声评估肝脂肪变性。
Medicine (Baltimore). 2022 Aug 19;101(33):e29708. doi: 10.1097/MD.0000000000029708.
2
US Attenuation for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative.美国肝脏脂肪定量衰减校正:AIUM-RSNA QIBA 脉冲回波定量超声倡议。
Radiology. 2022 Mar;302(3):495-506. doi: 10.1148/radiol.210736. Epub 2022 Jan 25.
3
Quantitative Evaluation of Hepatic Steatosis Using Advanced Imaging Techniques: Focusing on New Quantitative Ultrasound Techniques.
利用身体成分参数进行机器学习预测肝脂肪变性:一项英国生物银行研究。
NPJ Aging. 2024 Jan 9;10(1):4. doi: 10.1038/s41514-023-00127-z.
4
The Calculation and Evaluation of an Ultrasound-Estimated Fat Fraction in Non-Alcoholic Fatty Liver Disease and Metabolic-Associated Fatty Liver Disease.非酒精性脂肪性肝病和代谢相关脂肪性肝病中超声估计脂肪分数的计算与评估
Diagnostics (Basel). 2023 Oct 31;13(21):3353. doi: 10.3390/diagnostics13213353.
利用先进的影像学技术对肝脂肪变性进行定量评估:重点关注新的定量超声技术。
Korean J Radiol. 2022 Jan;23(1):13-29. doi: 10.3348/kjr.2021.0112.
4
Ultrasound Stratification of Hepatic Steatosis Using Hepatorenal Index.使用肝肾指数对肝脂肪变性进行超声分层
Diagnostics (Basel). 2021 Aug 10;11(8):1443. doi: 10.3390/diagnostics11081443.
5
Reliability of ultrasound hepatorenal index and magnetic resonance imaging proton density fat fraction techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy as the reference standard.超声肝肾指数和磁共振成像质子密度脂肪分数技术在诊断肝脂肪变性中的可靠性,以磁共振波谱为参考标准。
PLoS One. 2021 Aug 12;16(8):e0255768. doi: 10.1371/journal.pone.0255768. eCollection 2021.
6
Deep learning-based automated quantification of the hepatorenal index for evaluation of fatty liver by ultrasonography.基于深度学习的肝肾指数自动定量分析在超声评估脂肪肝中的应用
Ultrasonography. 2021 Oct;40(4):565-574. doi: 10.14366/usg.20179. Epub 2021 Feb 24.
7
Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.磁共振成像质子密度脂肪分数作为参考标准的非酒精性脂肪性肝病肝脂肪变性的定量超声射频数据分析。
Korean J Radiol. 2021 Jul;22(7):1077-1086. doi: 10.3348/kjr.2020.1262. Epub 2021 Mar 9.
8
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病相关肝细胞癌的全球流行病学:趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2021 Apr;18(4):223-238. doi: 10.1038/s41575-020-00381-6. Epub 2020 Dec 21.
9
Liver Steatosis Categorization on Contrast-Enhanced CT Using a Fully Automated Deep Learning Volumetric Segmentation Tool: Evaluation in 1204 Healthy Adults Using Unenhanced CT as a Reference Standard.使用全自动深度学习容积分割工具对增强 CT 进行肝脂肪变性分类:以未增强 CT 作为参考标准对 1204 例健康成年人进行评估。
AJR Am J Roentgenol. 2021 Aug;217(2):359-367. doi: 10.2214/AJR.20.24415. Epub 2020 Sep 16.
10
Diagnostic accuracy of B-Mode ultrasound and Hepatorenal Index for graduation of hepatic steatosis in patients with chronic liver disease.B 型超声及肝肾功能指数对慢性肝病患者肝脂肪变程度的诊断准确性。
PLoS One. 2020 May 1;15(5):e0231044. doi: 10.1371/journal.pone.0231044. eCollection 2020.